日本胃癌新分类及治疗指南：修订理念与主要修订要点 - Suppr

Suppr

超能文献

New Japanese classifications and treatment guidelines for gastric cancer: revision concepts and major revised points.

作者信息

Sano Takeshi, Aiko Takashi

机构信息

The Cancer Institute Hospital, Tokyo, Japan.

出版信息

Gastric Cancer. 2011 Jun;14(2):97-100. doi: 10.1007/s10120-011-0040-6.

DOI:10.1007/s10120-011-0040-6

PMID:21573921

Abstract

摘要

相似文献

New Japanese classifications and treatment guidelines for gastric cancer: revision concepts and major revised points.

Gastric Cancer. 2011 Jun;14(2):97-100. doi: 10.1007/s10120-011-0040-6.

[TNM-7th edition 2009 (UICC/AJCC) and Japanese Classification 2010 in Gastric Cancer. Towards simplicity and standardisation in the management of gastric cancer].

Cir Esp. 2011 May;89(5):275-81. doi: 10.1016/j.ciresp.2010.10.011. Epub 2011 Jan 21.

[Points of revision in the new Japanese treatment guidelines for gastric cancer].

Nihon Rinsho. 2012 Oct;70(10):1758-62.

Japanese gastric cancer treatment guidelines 2018 (5th edition).

Gastric Cancer. 2021 Jan;24(1):1-21. doi: 10.1007/s10120-020-01042-y. Epub 2020 Feb 14.

[Proposal for revision of guideline for treatment of stomach cancer].

Gan To Kagaku Ryoho. 2008 Sep;35(9):1505-8.

[Evaluation of the gastric cancer treatment guidelines of the Japanese Gastric Cancer Association].

Gan To Kagaku Ryoho. 2010 Apr;37(4):582-6.

TNM and Japanese staging systems for gastric cancer: how do they coexist?

Gastric Cancer. 2004;7(3):140-8. doi: 10.1007/s10120-004-0282-7.

[In regard to gastric cancer treatment guidelines--a revised edition].

Gan To Kagaku Ryoho. 2004 Nov;31(12):1947-51.

[Establishment of clinical practice guidelines for gastric cancer and its significance].

Nihon Rinsho. 2001 Apr;59 Suppl 4:287-94.

[Japanese Classification of Gastric Carcinoma (the 13th edition, June 1999): points to be revised].

Nihon Rinsho. 2001 Apr;59 Suppl 4:159-65.

引用本文的文献

Gene Amplification Might Be Associated with Lymph Node Metastasis of Gastric Cancer.

Genes (Basel). 2025 May 22;16(6):617. doi: 10.3390/genes16060617.

Prospects for the application of pathological response rate in neoadjuvant therapy for gastric cancer.

Front Oncol. 2025 Apr 11;15:1528529. doi: 10.3389/fonc.2025.1528529. eCollection 2025.

Efficacy of a linear stapler in entry hole closure during overlap anastomosis in minimally invasive gastrectomy.

Surg Endosc. 2025 May;39(5):3346-3353. doi: 10.1007/s00464-025-11736-y. Epub 2025 Apr 17.

Non-invasive liquid biopsy based on transcriptomic profiling for early diagnosis of occult peritoneal metastases in locally advanced gastric cancer.

NPJ Precis Oncol. 2025 Apr 15;9(1):109. doi: 10.1038/s41698-025-00875-z.

Development of a prognostic oxidative stress-immune-inflammation score and online calculators for predicting survival and recurrence in gastric cancer: a multicenter study.

Surg Endosc. 2025 Apr;39(4):2609-2624. doi: 10.1007/s00464-025-11596-6. Epub 2025 Mar 6.

Comprehensive analysis of risk factors associated with submucosal invasion in patients with early-stage gastric cancer.

World J Gastroenterol. 2024 Dec 21;30(47):5007-5017. doi: 10.3748/wjg.v30.i47.5007.

High Subcutaneous Adipose Tissue Radiodensity Predicts Poor Prognosis in Patients With Gastric Cancer.

Cancer Diagn Progn. 2024 Nov 3;4(6):754-761. doi: 10.21873/cdp.10392. eCollection 2024 Nov-Dec.

Breakfast Protein Intake of One-third of Daily Requirement Can Maintain Lean Body Mass Post-distal Gastrectomy.

In Vivo. 2024 Nov-Dec;38(6):2897-2903. doi: 10.21873/invivo.13771.

Re-evaluation of the role of endoscopic submucosal dissection in the treatment of early gastric cancer based on additional gastrectomy results.

Medicine (Baltimore). 2024 Oct 11;103(41):e40111. doi: 10.1097/MD.0000000000040111.

Are Palliative Interventions Worth the Risk in Advanced Gastric Cancer? A Systematic Review.

J Clin Med. 2024 Sep 28;13(19):5809. doi: 10.3390/jcm13195809.

本文引用的文献

Japanese classification of gastric carcinoma: 3rd English edition.

Gastric Cancer. 2011 Jun;14(2):101-12. doi: 10.1007/s10120-011-0041-5.

Japanese gastric cancer treatment guidelines 2010 (ver. 3).

Gastric Cancer. 2011 Jun;14(2):113-23. doi: 10.1007/s10120-011-0042-4.

Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002).

Gastric Cancer. 2011 Mar;14(1):72-80. doi: 10.1007/s10120-011-0009-5. Epub 2011 Feb 23.

Evaluation of the seventh American Joint Committee on Cancer/International Union Against Cancer Classification of gastric adenocarcinoma in comparison with the sixth classification.

Cancer. 2010 Dec 15;116(24):5592-8. doi: 10.1002/cncr.25550. Epub 2010 Aug 24.

Multicenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: the FLAGS trial.

J Clin Oncol. 2010 Mar 20;28(9):1547-53. doi: 10.1200/JCO.2009.25.4706. Epub 2010 Feb 16.

Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study.

Lancet Oncol. 2009 Nov;10(11):1063-9. doi: 10.1016/S1470-2045(09)70259-1. Epub 2009 Oct 7.

D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer.

N Engl J Med. 2008 Jul 31;359(5):453-62. doi: 10.1056/NEJMoa0707035.

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial.

Lancet Oncol. 2008 Mar;9(3):215-21. doi: 10.1016/S1470-2045(08)70035-4. Epub 2008 Feb 20.

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine.

N Engl J Med. 2007 Nov 1;357(18):1810-20. doi: 10.1056/NEJMoa072252.

Nodal dissection for patients with gastric cancer: a randomised controlled trial.

Lancet Oncol. 2006 Apr;7(4):309-15. doi: 10.1016/S1470-2045(06)70623-4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验